CEL-SCI Corporation (CVM) short interest & options flow
AMEXCEL-SCI Corporation has just gone through one of the most violent short-interest cycles seen in a micro-cap biotech this year — and with earnings four days away, the dust is far from settled. The short side of CVM exploded in early May. Short interest as a percentage of free float climbed from around 10% at the end of April to a peak of 50% on May 12 — a fivefold build…
CVM cost to borrow soars to 625% — up 846% in one week as short interest hits 49% of float.
- Market cap
- $25M
- Next earnings
- 21 Dec 2026
Key data as of 11 Nov 2026
Latest signals on CVM
- Cost to Borrow
CVM cost to borrow soars to 625% — up 846% in one week as short interest hits 49% of float.
- Short Interest
CVM short interest surges to 49.4% of float, up 240% in one week amid stock collapse. Cost to borrow explodes to 625%, highest recorded level. Biotech micro-cap experiencing extreme squeeze dynamics with utilization at 93%.
- Utilization
CVM short squeeze risk intensifies as SI utilization hits 93.2%, near 52-week peak of 98.5% reached yesterday.
CVM news and analysis
RSSNo long-form analysis yet for CVM. Pulse alerts and the live data picture are available on ORTEX.
Open CVM on ORTEX →Want the live picture for CVM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVM — free to start on ORTEX.
Sign up for free →Open CVM on ORTEX